Home Current Issue Previous Issues Published Ahead-of-Print Supplements Collections Podcasts Video Journal Info
Skip Navigation LinksHome > January 2013 - Volume 72 - Issue 1 > Increased xCT Expression Correlates With Tumor Invasion and...
Neurosurgery:
doi: 10.1227/NEU.0b013e318276b2de
Research-Human-Clinical Studies

Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas

Takeuchi, Satoru MD*; Wada, Kojiro MD*; Toyooka, Terushige MD*; Shinomiya, Nariyoshi MD; Shimazaki, Hideyuki MD§; Nakanishi, Kuniaki MD§; Nagatani, Kimihiro MD*; Otani, Naoki MD*; Osada, Hideo MD*; Uozumi, Yoichi MD*; Matsuo, Hirotaka MD; Nawashiro, Hiroshi MD*

Collapse Box

Abstract

BACKGROUND: xCT is a light chain of the cystine/glutamate antiporter system xc. Glutamate that is released by system xc plays an important role in the infiltration of glioblastoma (GBM) cells. Furthermore, increased glutathione synthesis by system xc may protect tumor cells against oxidative stress induced by radiotherapy and chemotherapy.

OBJECTIVE: To investigate whether the levels of xCT expression correlated with infiltrative imaging phenotypes on magnetic resonance imaging and outcomes in patients with GBMs.

METHODS: Forty patients with histologically confirmed primary GBMs were included in the study. Patient charts were retrospectively reviewed for age, sex, Karnofsky Performance Status Scale score, Mini-Mental State Examination score, magnetic resonance imaging features, xCT expression, isocitrate dehydrogenase 1 R132H expression, O6-methylguanine-DNA methyltransferase promoter methylation status, type of surgery, progression-free survival, and overall survival.

RESULTS: In invasive margins, xCT expression was weak in 20 patients and strong in 20 patients. A Cox regression model revealed that a Karnofsky Performance Status Scale score less than 60 (hazard ratio [HR]: 4.525; P = .01), partial removal (HR: 2.839; P = .03), and strong xCT expression (HR: 4.134; P < .001) were significantly associated with shorter progression-free survival and that partial removal (HR: 2.865; P = .03), weak isocitrate dehydrogenase 1 R132H expression (HR: 15.729; P = .01), and strong xCT expression (HR: 2.863; P = .04) were significantly associated with shorter overall survival.

CONCLUSION: These findings suggest that xCT is an independent predictive factor in GBMs.

ABBREVIATIONS: EAAT-2, excitatory amino acid transporter 2

GBM, glioblastoma

GSH, glutathione

IDH1, isocitrate dehydrogenase 1

KPS, Karnofsky Performance Status Scale

MGMT, O6-methylguanine–DNA methyltransferase

MMSE, Mini-Mental Status Examination

OS, overall survival

PFS, progression-free survival

Copyright © by the Congress of Neurological Surgeons

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.